- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01098175
Peritoneal Cavity Conditioning During Open Surgery.
Peritoneal Cavity Conditioning During Open Surgery Decreases Postoperative Pain and Inflammation and Decreases Time to Restore Transit
Study Overview
Status
Conditions
Detailed Description
Aim of the Trial :
RCT demonstrating that peritoneal cavity conditioning during open surgery will result in a less postoperative inflammation, less postoperative pain, and shorter time to flatus and transit.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZ Gasthuisberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria :
- patients will be stratified and randomised according to the type of surgery
- total laparoscopic hysterectomy,
- promontofixation
- cholecystectomy
Exclusion criteria :
- Any pre-existing condition increasing the risk of surgery such as age, pre-existing conditions as clotting disorders, heart or lung impairment etc.
- Not signed informed consent
- known allergic reaction to Sprayshield, Intercoat of hyalobarrier gel ® or - any bowel lesion requiring a single or double layer suture. (given that for none of the any anti-adhesion barriers safety has been proven following bowel lesions and suture)
- Any condition that might interfere with inflammatory parameters or pre-existing such as ,pregnancy, immunodeficiency, chronic inflammatory disease as Crohn's disease, chronic pain conditions as (peripheral neuropathy, pathology of the vertebral column and osteo-articular disease, any condition causing acute pain e.g. trauma.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Control group
open surgery with exposure of the surgical wound to the air.
|
Full peritoneal conditioning
Full peritoneum cavity conditioning will be performed as follows.
A continuous flow of less than 0.5 l/min of gas will be instilled in the lowest part of the operating wound.
As gas premixed bottles with CO2+ 4% of oxygen and 10% of N2O will be used.
This gas will be humidified and at 31-32 °C to be achieved by a commercial humidifier (Fisher and Paykel) programmed in order to maintain 100% relative humidity at 31-32°C upon entrance of the peritoneal cavity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary endpoint : decreased pain on day 1 and 2 after surgery
Time Frame: 0 to 7 days
|
Postoperative pain : will be assessed by visual analog scales (cfr Trial by Verguts & Koninckx, addendum I) assessed pain on day 1, 2 and 3 after surgery.
Pain medication will be free, but preferentially ibuprofen will be used in order to permit easier comparison of pain killer intake.
|
0 to 7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
decrease in CRP and inflammatory parameters on day 1 and 2 or longer
Time Frame: day 1-4
|
Postoperative inflammatory reaction : daily assessment of inflammatory parameters as CRP, leucocytosis , and temperature for 4 to 7 days are done routinely today. In some subsets of patients other more specific inflammatory parameters as Ca125, IL-6 can be investigated |
day 1-4
|
lower peritoneal fluid volume on day 2
Time Frame: day 2 after surgery
|
Estimation of peritoneal fluid volume by ultrasound on the second day after surgery will be performed in some subsets of patients.
We indeed recently validated a non-invasive and reliable assessment of peritoneal fluid volume by ultrasound.
(Verguts et all, 2009) We expect that the postoperative peritoneal fluid volume will increase with the degree of peritoneal inflammation.
|
day 2 after surgery
|
Shorter time to resumption of transit: time to first flatus and time to first stool
Time Frame: day1 to 5
|
Time to first flatus and time to first stool will be recorded
|
day1 to 5
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: philippe R Koninckx, MD, UZ Gasthuisberg, KULeuven
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- S52233
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracotomy
-
University of Maryland, BaltimoreAtriCure, Inc.RecruitingChronic Post-thoracotomy Pain | Post-thoracotomy Pain Syndrome | Acute Post-thoracotomy PainUnited States
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Yuzuncu Yıl UniversityUnknown
-
Yeungnam University College of MedicineUnknownThoracotomyKorea, Republic of
-
Attikon HospitalCompleted
-
Integra LifeSciences CorporationTerminated
-
University Hospital Inselspital, BerneCompletedThoracotomy | SternotomySwitzerland
-
Tanta UniversityRecruiting
-
Methodist Health SystemEnrolling by invitation
-
Assistance Publique Hopitaux De MarseilleTerminated